Identification of potential inhibitors of SARS-CoV-2 main protease from Aloe vera compounds: A molecular docking study.
Chem Phys Lett
; 754: 137751, 2020 Sep.
Article
in English
| MEDLINE | ID: covidwho-625136
ABSTRACT
SARS-CoV-2 is the pathogen agent of the new corona virus disease that appeared at the end of 2019 in China. There is, currently, no effective treatment against COVID-19. We report in this study a molecular docking study of ten Aloe vera molecules with the main protease (3CLpro) responsible for the replication of coronaviruses. The outcome of their molecular simulation and ADMET properties reveal three potential inhibitors of the enzyme (ligands 6, 1 and 8) with a clear preference of ligand 6 that has the highest binding energy (-7.9 kcal/mol) and fully obeys the Lipinski's rule of five.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Prognostic study
Language:
English
Journal:
Chem Phys Lett
Year:
2020
Document Type:
Article
Affiliation country:
J.cplett.2020.137751
Similar
MEDLINE
...
LILACS
LIS